Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Utah Medical Products (UTMD) EBT Margin (2016 - 2025)

Utah Medical Products (UTMD) has 16 years of EBT Margin data on record, last reported at 33.72% in Q3 2025.

  • For Q3 2025, EBT Margin fell 805.0% year-over-year to 33.72%; the TTM value through Sep 2025 reached 39.3%, up 2334.0%, while the annual FY2024 figure was 41.08%, 108.0% up from the prior year.
  • EBT Margin reached 33.72% in Q3 2025 per UTMD's latest filing, down from 38.54% in the prior quarter.
  • Across five years, EBT Margin topped out at 183.47% in Q4 2024 and bottomed at 50.71% in Q4 2022.
  • Average EBT Margin over 5 years is 37.39%, with a median of 39.73% recorded in 2025.
  • Peak YoY movement for EBT Margin: plummeted -9083bps in 2022, then soared 23336bps in 2024.
  • A 5-year view of EBT Margin shows it stood at 40.12% in 2021, then plummeted by -226bps to 50.71% in 2022, then increased by 2bps to 49.89% in 2023, then skyrocketed by 468bps to 183.47% in 2024, then crashed by -82bps to 33.72% in 2025.
  • Per Business Quant database, its latest 3 readings for EBT Margin were 33.72% in Q3 2025, 38.54% in Q2 2025, and 39.73% in Q1 2025.